According to the recent study the biologics safety testing market is projected to reach an estimated $8.2 billion by 2028 from $4.5 billion in 2023, at a CAGR of 12.8% from 2023 to 2028. Growth in this market is primarily driven by increasing pharmaceutical and biotechnology industry, rising concerns over cell culture contamination, and growing R&D investment in life science segment.
A more than 150–page
report is developed to understand trends, opportunities and forecast in
biologics safety testing market by type (endotoxin test, sterility test,
mycoplasma tests, bioburden tests, residual host-cell proteins & DNA
detection tests, virus safety test, and others), product & service
(consumables, instrument, and services), application (vaccine development and
manufacturing, monoclonal antibodies development and manufacturing, cellular
& gene therapy product development and manufacturing, blood and blood
product development and manufacturing, and others), and region.
Download sample report by clicking
on below link
https://www.lucintel.com/biologics-safety-testing-market.aspx
“Residual host-cell proteins & DNA
detection tests market is expected to remain the largest segment during the
forecast period.”
Based on type, the
biologics safety testing market is segmented into endotoxin test, sterility
test, mycoplasma tests, bioburden tests, residual host-cell proteins & DNA
detection tests, virus safety test, and other. Lucintel forecasts that the
residual host-cell proteins & DNA detection tests market is expected to
remain the largest segment as it enables the biopharmaceutical manufacturers to
demonstrate the safety and purity of their products before the regulatory
authorities by testing for residual host cell proteins and DNA.
“Within the biologics safety testing market, the vaccine
development and manufacturing segment is expected to remain the largest
application.”
Based on application the
vaccine development and manufacturing segment is expected to witness the
highest growth over the forecast period due to increasing number of infectious
diseases and growing necessity of biologics safety testing for quality
assurance.
“North America will dominate the biologics safety testing market
in near future.”
North America is
expected to remain the largest region over the forecast period due to
increasing investment in R&D in the biopharmaceutical industry, growing
number of biological products and novel drugs, and rising awareness among
population towards product safety.
Download Brochure of this report by clicking on https://www.lucintel.com/biologics-safety-testing-market.aspx.
Major players of
biologics safety testing market are adopting various growth strategies like new
product launches, expansions, merger and acquisitions, partnerships,
agreements, and collaborations to expand their presence in this market. Charles
River Laboratories, Lonza, Thermo Fisher Scientific, Merck KGaA, and F.
Hoffmann-La Roche are among the major biologics safety testing providers.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or click on this link https://www.lucintel.com/biologics-safety-testing-market.aspx or helpdesk@lucintel.com.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times. For further information, visit www.lucintel.com.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related reports
Healthcare
IT Market:
For more details click here https://www.lucintel.com/healthcare-it-market.aspx
Medical
Holography Market:
For more details click here https://www.lucintel.com/medical-holography-market.aspx
Electrophysiology Market:
For more details click here https://www.lucintel.com/electrophysiology-market.aspx
Minimally Invasive Surgical Instrument Market:
For more details click here https://www.lucintel.com/minimally-invasive-surgical-instrument-market.aspx
Endoscopy Equipment Market:
For more details click here https://www.lucintel.com/endoscopy-equipment-market.aspx
Surgical Instrument Tracking System Market:
For more details click here https://www.lucintel.com/elastomeric-foam-insulation-market.aspx
Metabolomics
Market:
For more details click here https://www.lucintel.com/metabolomics-market.aspx
Industrial Microbiology Market:
For more details click here https://www.lucintel.com/opportunities-in-the-industrial-microbiologycolonopt-size,-trends-and-growth-analysis.aspx
Surgical
Microscope Market:
For more details click here https://www.lucintel.com/surgical-microscope-market.aspx
Tumor Ablation Market:
No comments:
Post a Comment